The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, phase I clinical trial of SHR-9839 in patients with advanced
solid tumors. The whole study is divided into three stages: dose escalation, dose expansion
and efficacy expansion.